{
    "2018-09-07": [
        [
            {
                "time": "2018-09-07",
                "original_text": "等了45天迈瑞医疗终拿IPO批文，募资或缩水超3成",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "IPO",
                        "募资缩水"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "沪指勉强收复2700点，看好白马股估值回归及有业绩支撑超跌股机会",
                "features": {
                    "keywords": [
                        "沪指",
                        "白马股",
                        "估值回归",
                        "超跌股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "9月7日复盘：多头反攻在望主力重点出击5股(名单)",
                "features": {
                    "keywords": [
                        "多头反攻",
                        "主力出击",
                        "复盘"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "343亿资金争夺20股：主力资金重点出击5股(名单)",
                "features": {
                    "keywords": [
                        "资金争夺",
                        "主力资金",
                        "重点出击"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "09月07日 主力资金抢筹最积极的前10股（附名单）",
                "features": {
                    "keywords": [
                        "主力资金",
                        "抢筹",
                        "积极"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "医药行业：行业持续稳健增长分化明显强者恒强",
                "features": {
                    "keywords": [
                        "医药行业",
                        "稳健增长",
                        "强者恒强"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "恒瑞医药注射用紫杉醇批准注册 将用于治疗转移性乳腺癌等",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "紫杉醇",
                        "治疗乳腺癌"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "资金撤离大盘蓝筹 市场底部特征再现",
                "features": {
                    "keywords": [
                        "资金撤离",
                        "大盘蓝筹",
                        "市场底部"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "恒瑞医药：紫杉醇（白蛋白结合型）获批 抗肿瘤又添大品种",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "紫杉醇",
                        "抗肿瘤"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-07",
                "original_text": "6家药企亚洲最强",
                "features": {
                    "keywords": [
                        "药企",
                        "亚洲最强"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}